Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration [Docket No. FDA-2010-N-0001]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Notice.
 SUMMARY: The Food and Drug Administration (FDA) is announcing that we have revised the Advisory Committee Information Hotline (the hotline). The hotline provides the public with access to the most current information available on FDA advisory committee meetings. This notice supersedes all previously published announcements of FDA's Advisory Committee Information Hotline.
 FOR FURTHER INFORMATION CONTACT: Michael F. Ortwerth, Director, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.


SUPPLEMENTARY INFORMATION: The Advisory Committee Information Hotline can be accessed by dialing 1-800-741-8138 or 301-443-0572. The advisory committee meeting information and information updates can also be accessed via FDA's Advisory Committee Internet site at 
                    *http://www.fda.gov/​AdvisoryCommittees/​default.htm*. Each advisory committee is assigned a 10-digit number. This 10-digit number will appear in each individual notice of meeting. The public can obtain information about a particular advisory committee meeting by using the committee's 10-digit number. Information on the hotline is preliminary and may change before a meeting is actually held. The hotline will be updated when such changes are made. The following is a list of each advisory committee's 10-digit number to be used when accessing the hotline. The list has been updated to add the newly established advisory committee in the Center for Tobacco called the Tobacco Products Scientific Advisory Committee. Advisory Committee
10-Digit Access NumberOFFICE OF THE COMMISSIONERPediatric Advisory Committee
8732310001Risk Communication Advisory Committee
8732112560Science Board to the FDA
3014512603CENTER FOR BIOLOGICS EVALUATION AND RESEARCHAllergenic Products Advisory Committee
3014512388Blood Products Advisory Committee
3014519516Cellular, Tissue & Gene Therapies Advisory Committee
3014512389Transmissible Spongiform Encephalopathies Advisory Committee
3014512392Vaccines and Related Biological Products Advisory Committee
3014512391CENTER FOR DRUG EVALUATION AND RESEARCHAnesthetic and Life Support Drugs Advisory Committee
3014512529Anti-Infective Drugs Advisory Committee
3014512530Antiviral Drugs Advisory Committee
3014512531Arthritis Advisory Committee
3014512532Cardiovascular and Renal Drugs Advisory Committee
3014512533Dermatologic and Ophthalmic Drugs Advisory Committee
3014512534Drug Safety and Risk Management Advisory Committee
3014512535Endocrinologic and Metabolic Drugs Advisory Committee
3014512536Gastrointestinal Drugs Advisory Committee
3014512538Nonprescription Drugs Advisory Committee
3014512541Oncologic Drugs Advisory Committee
3014512542Peripheral and Central Nervous System Drugs Advisory Committee
3014512543Pharmaceutical Science & Clinical Pharmacology, Advisory Committee for (formerly Advisory Committee for Pharmaceutical Science)
3014512539( print page 9417)Psychopharmacologic Drugs Advisory Committee
3014512544Pulmonary-Allergy Drugs Advisory Committee
3014512545Reproductive Health Drugs, Advisory Committee for
3014512537CENTER FOR FOOD SAFETY AND APPLIED NUTRITIONFood Advisory Committee
3014510564CENTER FOR DEVICES AND RADIOLOGICAL HEALTHDevice Good Manufacturing Practice Advisory Committee
3014512398Medical Devices Advisory Committee comprised of 18 panels)Anesthesiology and Respiratory Therapy Devices Panel
3014512624Circulatory System Devices Panel
3014512625Clinical Chemistry and Clinical Toxicology Devices Panel
3014512514Dental Products Panel
3014512518Ear, Nose, and Throat Devices Panel
3014512522Gastroenterology-Urology Devices Panel
3014512523General and Plastic Surgery Devices Panel
3014512519General Hospital and Personal Use Devices Panel
3014512520Hematology and Pathology Devices Panel
3014512515Immunology Devices Panel
3014512516Medical Devices Dispute Resolution Panel
3014510232Microbiology Devices Panel
3014512517Molecular and Clinical Genetics Panel
3014510231Neurological Devices Panel
3014512513Obstetrics-Gynecology Devices
3014512524Ophthalmic Devices Panel
3014512396Orthopaedic and Rehabilitation Devices Panel
3014512521Radiological Devices Panel
3014512526National Mammography Quality Assurance Advisory Committee
3014512397Technical Electronic Product Radiation Safety Standards Committee
3014512399CENTER FOR TOBACCOTobacco Products Scientific Advisory Committee
8732110002CENTER FOR VETERINARY MEDICINEVeterinary Medicine Advisory Committee
3014512548NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH (NCTR)Science Advisory Board to NCTR
3014512559
 The hotline will provide the most recent information available on upcoming advisory committee meetings, guidance for making an oral presentation during the open public hearing portion of a meeting, and procedures on obtaining copies of transcripts of advisory committee meetings. Because the hotline will communicate the most current information available about any particular advisory committee meeting, this system will provide interested parties with timely and equal access to such information. The hotline should 
                    ( print page 9418)
                    also conserve agency resources by reducing the current volume of inquiries individual FDA offices and employees must handle concerning advisory committee schedules and procedures. This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees. Dated: February 24, 2010. Joanne Less, Acting Associate Commissioner for Special Medical Programs.


[FR Doc. 2010-4258 Filed 3-1-10; 8:45 am] BILLING CODE 4160-01-S